about
Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited GuestsThe indoleamine 2,3-dioxygenase (IDO) pathway controls allergyImplication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allograftsTrial watch: IDO inhibitors in cancer therapyThe ternary complex of PrnB (the second enzyme in the pyrrolnitrin biosynthesis pathway), tryptophan, and cyanide yields new mechanistic insights into the indolamine dioxygenase superfamilyAnti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients.Indoleamine 2,3-dioxygenase 1 is a lung-specific innate immune defense mechanism that inhibits growth of Francisella tularensis tryptophan auxotrophsEPR and Mössbauer spectroscopy show inequivalent hemes in tryptophan dioxygenase.Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells.Regulation of tryptophan 2,3-dioxygenase by HOXA10 enhances embryo viability through serotonin signalingIn vitro characterization of echinomycin biosynthesis: formation and hydroxylation of L-tryptophanyl-S-enzyme and oxidation of (2S,3S) β-hydroxytryptophanRegulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients.Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential.Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers.HIV and the gut microbiota, partners in crime: breaking the vicious cycle to unearth new therapeutic targets.Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease modelsRaman spectroscopy detects melanoma and the tissue surrounding melanoma using tissue-engineered melanoma models.Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis.Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation.Role of IDO in organ transplantation: promises and difficulties.Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma.Possible roles of excess tryptophan metabolites in cancer.Placental expression of indoleamine 2,3-dioxygenase.TDO as a therapeutic target in brain diseases.Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes.Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression.Differential expression and regulation of Ido2 in the mouse uterus during peri-implantation period.Mass spectrometric measurement of urinary kynurenine-to-tryptophan ratio in children with and without urinary tract infection.
P2860
Q26797214-157FA383-8742-415C-90F5-DA047A1B7058Q26822976-F853C22E-C2FA-4D43-B907-9E31454AF525Q26825202-44FEC27B-483D-4A35-981E-9DF9EFB8AA63Q27006866-0B51C8CB-73BA-4757-812C-58EEA5AF2410Q27660883-68C4D677-0CBB-4DED-A79F-4814914E7C3FQ33830637-12AE5EE3-A117-42A7-B231-B4AE4716F5F9Q33877246-DBF8A789-0E21-4F89-8CB3-65AEE9C33121Q34090851-B36A048D-A33A-4AEF-8AFA-85E1820E6989Q34485130-F3977A3B-9B4D-41F7-9469-DBC73730AC92Q34501773-2A4A4654-4EF5-4A24-93BD-9F8CEFE69BC3Q34599431-C71B92F2-2A0A-4964-8EF8-CCDA05176DCBQ34645439-79E13669-C513-4050-B3F7-8831D630E07FQ35005881-2E94DA33-12B4-4D32-850F-5ECF2C62F3A1Q35023537-34632893-F85F-4A13-9711-58B12954F20BQ35156136-B919F674-B6FF-4178-8943-53BF94FC4352Q36525166-5D8440C4-8D27-4C0A-9DC5-93358365BEEAQ36861803-87078DBB-7FCB-426A-A596-1809CC4D6BD0Q37399410-0632E861-0B70-448F-A47E-4F3D2AEA0AD0Q37424082-12DB696E-BC0D-4F91-80DF-B02241E06BA2Q37610449-82D63BC8-83B3-4F64-9E7A-EE28CB42A4AAQ37742979-D59A5F2B-ABF7-4D95-89D3-E7254DE78451Q37788635-5C1E84B5-F0CE-42C8-9EF8-E809FFF5D9C5Q38020356-D5119BD5-A8EC-460B-A6A8-4357739ACC3BQ38806660-6E5D2B07-B80B-461B-8046-5A068249EFF0Q41376143-1A81E892-8C12-4A0A-BFEE-922C57DE82C7Q43230804-C80911FA-A2FD-4489-93D9-71ACC841C256Q49592866-0CD6FF16-7032-4CBB-A3B4-9171240179B2Q50623114-FCDFB150-461A-4981-9768-B18C5B03D10FQ54231167-5EB586CD-3110-4FA6-954D-5AA7F0CF027B
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Exploring the mechanism of tryptophan 2,3-dioxygenase
@ast
Exploring the mechanism of tryptophan 2,3-dioxygenase
@en
Exploring the mechanism of tryptophan 2,3-dioxygenase
@nl
type
label
Exploring the mechanism of tryptophan 2,3-dioxygenase
@ast
Exploring the mechanism of tryptophan 2,3-dioxygenase
@en
Exploring the mechanism of tryptophan 2,3-dioxygenase
@nl
prefLabel
Exploring the mechanism of tryptophan 2,3-dioxygenase
@ast
Exploring the mechanism of tryptophan 2,3-dioxygenase
@en
Exploring the mechanism of tryptophan 2,3-dioxygenase
@nl
P2093
P2860
P356
P1476
Exploring the mechanism of tryptophan 2,3-dioxygenase
@en
P2093
Christopher G Mowat
Sarah J Thackray
Stephen K Chapman
P275
P2860
P304
P356
10.1042/BST0361120
P577
2008-12-01T00:00:00Z